NervGen Pharma Corp. Common stock (NGEN) Research Hub

NervGen Pharma Corp. Common stock (NGEN) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.42 USD (-0.70%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.41, market cap 0.14B. This hub links to the full technical, earnings and options research available for NGEN.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, CA
Last close1.42 USD (-0.70%)
52-week range1.37 USD – 2.4 USD
Trend regimeRange
14-day RSI15.6 (Oversold)
Trailing P/E-8.41
Market cap0.14B
Dividend yield0.00%
Next earnings2026-08-21

Available research for NGEN

Earnings

NGEN earnings date and last-quarter result: next report 2026-08-21, last quarter beat, P/E -8.41. Updated 2026-07-23.

Options: Covered Call

Covered Call on NGEN: how it works, illustrative setup around the real 1.42 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on NGEN: how it works, illustrative setup around the real 1.42 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on NGEN: how it works, illustrative setup around the real 1.42 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

NGEN technical analysis: range, last 1.42 USD, RSI 15.6, 52w range 1.37 USD–2.4 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is NGEN in?

NervGen Pharma Corp. Common stock (NGEN) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.

Is NGEN in an uptrend or downtrend?

As of 2026-10-26, NGEN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is NGEN's trailing P/E ratio?

NGEN's trailing P/E is -8.41, with a market cap of 0.14B. See the earnings research page for full valuation detail.

When does NGEN next report earnings?

NGEN is next scheduled to report earnings on 2026-08-21.